siRNA therapy reduces triglycerides in individuals with uncommon ailment

.INVESTIGATION FEATURE.19 September 2024.

Plozasiran lowered triglyceride degrees through 80% and lowered the danger of pancreatitis in people with chronic chylomicronemia, with or even without a hereditary medical diagnosis.